Drug resistance in antiviral therapy

Clinics in Liver Disease
Stephen Locarnini, Scott Bowden

Abstract

The introduction of nucleos(t)ide analog therapy has seen the emergence of antiviral drug resistance, which has become the main factor limiting the long-term application of these antiviral agents for patients with chronic hepatitis B. The prevention of resistance requires the adoption of strategies that effectively control virus replication and exploit an understanding of the mechanisms and processes that drive the emergence of drug resistance, namely high replication rates, low fidelity of the hepatitis B virus rt/polymerase, selective pressure of the nucleos(t)ide analog, role of replication space (liver turnover), fitness of the mutant, and genetic barrier to the drug.

References

Jun 1, 1989·Virology·R Girones, R H Miller
Jan 1, 1995·Annual Review of Immunology·F V Chisari, C Ferrari
Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·M A NowakH McDade
Dec 22, 1999·Journal of Viral Hepatitis·T Shaw, S A Locarnini
Mar 8, 2000·Microbiology and Molecular Biology Reviews : MMBR·C Seeger, W S Mason
May 9, 2000·Journal of Virology·Y Y Zhang, J Summers
May 29, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C T YehY F Liaw
Sep 26, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D D Richman
Oct 26, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S NafaF Zoulim
Oct 5, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M F YuenC L Lai
Oct 27, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S R LewinA S Perelson
Dec 13, 2001·AIDS·Vincent ThibaultChristine Katlama
Aug 13, 2002·Journal of Medical Microbiology·Hubert G M NiestersAlbert D M E Osterhaus
Mar 11, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ching-Lung LaiLynn Condreay
Jun 28, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Martin S HirschDouglas D Richman
Mar 5, 2004·The New England Journal of Medicine·François Clavel, Allan J Hance
Sep 17, 2004·The New England Journal of Medicine·Patrick MarcellinUNKNOWN Peginterferon Alfa-2a HBeAg-Negative Chronic Hepatitis B Study Group
Oct 8, 2004·The New England Journal of Medicine·Yun-Fan LiawUNKNOWN Cirrhosis Asian Lamivudine Multicentre Study Group
Nov 30, 2004·Expert Review of Anti-infective Therapy·Tim Shaw, Stephen Locarnini
Jan 20, 2005·Proceedings of the National Academy of Sciences of the United States of America·William S MasonJesse Summers
May 26, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Marie-Noëlle BrunelleFabien Zoulim
Jul 1, 2005·The New England Journal of Medicine·Stephanos J HadziyannisUNKNOWN Adefovir Dipivoxil 438 Study Group
Jul 1, 2005·The New England Journal of Medicine·George K K LauUNKNOWN Peginterferon Alfa-2a HBeAg-Positive Chronic Hepatitis B Study Group
Aug 17, 2005·Seminars in Liver Disease·Stephen Locarnini
Dec 21, 2005·Journal of Hepatology·Stephen Locarnini, William S Mason
Jan 5, 2006·JAMA : the Journal of the American Medical Association·Chien-Jen ChenUNKNOWN REVEAL-HBV Study Group
Feb 4, 2006·Journal of Hepatology·Tim ShawStephen Locarnini
Apr 28, 2006·The New England Journal of Medicine·Oliver SchildgenWolfram H Gerlich
Jul 21, 2006·The New England Journal of Medicine·Ting-Tsung Chang, Ching-Lung Lai
Aug 31, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hyung Joon YimAnna S F Lok
Nov 8, 2006·Gastroenterology·Stephanos J HadziyannisUNKNOWN Adefovir Dipivoxil 438 Study Group
Nov 30, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Richard J ColonnoDaniel J Tenney
Jan 12, 2007·Antiviral Research·Lilly K W YuenAngeline Bartholomeusz
Apr 20, 2007·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Fumitaka SuzukiHiromitsu Kumada
Jun 29, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Anna S LokUNKNOWN Hepatitis B Virus Drug Resistance Working Group
Aug 9, 2007·Journal of Molecular Evolution·Yang Zhou, Edward C Holmes

❮ Previous
Next ❯

Citations

Jun 15, 2012·Journal of Gastroenterology and Hepatology·Cheng WangJinlin Hou
Jan 18, 2013·World Journal of Gastroenterology : WJG·Zhuo-Lun SongHong Zheng
Mar 21, 2013·Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology·Deepak N Amarapurkar, Nikhil Patel
Sep 6, 2013·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Kathrine Stene-Johansen, Regine Barlinn
Feb 22, 2012·Clinics and Research in Hepatology and Gastroenterology·Julien DupoueyPhilippe Colson
Sep 19, 2015·Current Opinion in Infectious Diseases·Thinesh Lee Krishnamoorthy, David Mutimer
Apr 20, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Chao-Wei Hsu, Chau-Ting Yeh
Sep 16, 2011·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Lihui Deng, Hong Tang
Sep 21, 2013·Journal of Chemical Information and Modeling·Chaitanya A K KoppisettyPer-Georg Nyholm
May 15, 2020·Clinical Microbiology Reviews·Naveen KumarBarry T Rouse

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.